Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the April 2025 reimbursement prices for the following products, to reflect an increase in their NHS list prices.
To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed to grant retrospective price adjustments for the following products prescribed by brand or generically.
| Generic name | Brand name | Pack size | Previous NHS list price | Redetermined reimbursement price for April 2025 | Drug Tariff Category |
| Dimeticone 22% / Benzalkonium chloride 0.1% cream | Conotrane® cream (Evolan Pharma AB) 500 gram | 500 grams | £4.98 | £9.19 | Not in Drug Tariff |
| Dalteparin sodium 10,000units/0.4ml solution for injection pre-filled syringes | Fragmin® 10,000units/0.4ml solution for injection pre-filled syringes (Pfizer Ltd) | 5 pre-filled disposable injections | £28.23 | £34.11 | Category C – based on Fragmin® |
| Phentolamine 2mg/0.35ml / Aviptadil 25micrograms/0.35ml solution for injection ampoules | Invicorp® 25micrograms/2mg/0.35ml solution for injection ampoules (Evolan Pharma AB) | 5 ampoules | £47.50 | £61.23 | Category C – based on Invicorp® |
| Macrogol 3350 oral powder 8.5g sachets sugar free | TransiSoft® oral powder 8.5g sachets (Mayoly UK Ltd) | 28 sachets | £188.84 | £217.17 | Category C – based on Transisoft® |
| Generic Thick & Easy powder | Thick & Easy® Original powder (Fresenius Kabi Ltd) | 4540 grams | £128.02 | £131.73 | Not in Drug Tariff |
| Zinc oxide impregnated medicated stockings | Zipzoc® stockings (Evolan Pharma AB) | 4 stockings | £15.90 | £22.12 | Category C – based on Zipzoc® |
| Zinc oxide impregnated medicated stockings | Zipzoc® stockings (Evolan Pharma AB) | 10 stockings | £39.75 | £55.29 | Category C – based on Zipzoc® |
Under the current price change mechanism, pharmacy owners would have to wait one (or in some cases two months) before any NHS list prices changes are applied to reimbursement of branded products. The delays in reimbursement prices catching up with any NHS list price increases can lead to dispensing at a loss, as pharmacies will be reimbursed based on the previous NHS list price until the price change is adjusted in line with the price change timetable. The impact is more significant for products with large list price increases or for high volume lines.
To avoid pharmacy owners dispensing these products at a loss, Community Pharmacy England requested DHSC to redetermine the April 2025 reimbursement prices for the products listed above.
Pricing adjustments for the above products are planned to be included in the May 2025 Schedule of Payments (with a payment date of 1st August 2025). The payments will appear as ‘Adjustment drugs‘ and ‘Adjustment fees’ (if applicable). The adjustments for products listed above will be shown as a combined total.
Community Pharmacy England sought price adjustments to several other products affected by NHS list price increases in April 2025. However, DHSC took the decision not to grant price redeterminations for all the products requested. Community Pharmacy England continues to seek a review of the current price change timetable for branded products so that there is no extra months’ delay in applying any new list prices changes to reimbursement.
The post Retrospective reimbursement prices for April 2025 appeared first on Community Pharmacy England.